All News #Library
FDA Issues Form 483 to Boehringer Ingelheim Biopharmaceuticals
30 Oct 2024 //
FDA
Enforcement Report - Week of March 29, 2023
29 Mar 2023 //
FDA
Enforcement Report- Week of June 9, 2021
09 Jun 2021 //
FDA
Enforcement Report - Week of November 7, 2018
07 Nov 2018 //
FDA
Enforcement Report - Week of October 3, 2018
03 Oct 2018 //
FDA
Enforcement Report - Week of February 7, 2018
07 Feb 2018 //
FDA
Enforcement Report - Week of October 18, 2017
18 Oct 2017 //
FDA
SGLT2 Inhibitors - Risk of Diabetic Ketoacidosis
16 May 2016 //
HEALTH CANADA
Boehringer recalls Furosemide Tablets due to CGMP Deviations
22 Oct 2015 //
FDA

Market Place
Sourcing Support